Mark Mallon

Business address
C/O Ironwood Pharmaceuticals, Inc., 100 Summer Street, Suite 2300, Boston, MA, 02110
Top holdings (ownership)
NEO
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Mark Mallon has filed 12 SEC EDGAR filings since 11 Jan 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 03 Mar 2022 01 Mar 2022 001-35756
4 Open Document Open Filing FORM 4 30 Dec 2021 30 Dec 2021 001-35756
4 Open Document Open Filing FORM 4 06 Dec 2021 06 Dec 2021 001-35756
4 Open Document Open Filing FORM 4 21 Apr 2021 19 Apr 2021 001-35756
3 Open Document Open Filing FORM 3 21 Apr 2021 19 Apr 2021 001-35756
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2021 26 Feb 2021 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION 13 May 2020 11 May 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2020 27 Feb 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION 25 Feb 2020 21 Feb 2020 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION 03 Apr 2019 01 Apr 2019 001-34620
4 Open Document Open Filing FORM 4 SUBMISSION 11 Jan 2019 09 Jan 2019 001-34620
3 Open Document Open Filing FORM 3 SUBMISSION 11 Jan 2019 04 Jan 2019 001-34620